{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=MEDI-507&page=2", "query": { "intervention": "MEDI-507", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=MEDI-507&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-27T04:09:38.777Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01780454", "title": "Renal Allograft Tolerance Through Mixed Chimerism", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "End Stage Renal Disease" ], "interventions": [ { "name": "MEDI-507", "type": "DRUG" }, { "name": "Rituximab", "type": "DRUG" }, { "name": "Total Body Irradiation", "type": "RADIATION" }, { "name": "Thymic Irradiation", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 2, "start_date": "2013-03", "completion_date": "2020-06", "has_results": true, "last_update_posted_date": "2021-04-19", "last_synced_at": "2026-09-27T04:09:38.777Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01780454" }, { "nct_id": "NCT06078696", "title": "Siplizumab for Sickle Cell Disease Transplant", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Anemia, Sickle Cell" ], "interventions": [ { "name": "Siplizumab", "type": "DRUG" }, { "name": "Exchange Transfusion", "type": "PROCEDURE" }, { "name": "Total Body Irradiation", "type": "PROCEDURE" }, { "name": "Stem Cell Infusion", "type": "PROCEDURE" }, { "name": "Cyclophosphamide 50mg", "type": "DRUG" }, { "name": "Mesna", "type": "DRUG" }, { "name": "Sirolimus Oral Tablet", "type": "DRUG" }, { "name": "Rituximab or Biosimilar", "type": "DRUG" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 1, "start_date": "2023-09-28", "completion_date": "2025-12-11", "has_results": true, "last_update_posted_date": "2026-06-10", "last_synced_at": "2026-09-27T04:09:38.777Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06078696" }, { "nct_id": "NCT00105313", "title": "Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Lymphoma", "Leukemia", "Cancer" ], "interventions": [ { "name": "MEDI-507", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "MedImmune LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 80, "start_date": "2005-02", "completion_date": null, "has_results": false, "last_update_posted_date": "2007-06-14", "last_synced_at": "2026-09-27T04:09:38.777Z", "location_count": 11, "location_summary": "Los Angeles, California • New Haven, Connecticut • Washington D.C., District of Columbia + 8 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Tampa", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00105313" }, { "nct_id": "NCT00063817", "title": "Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "End-stage Renal Disease", "Renal Transplantation", "Kidney Transplantation" ], "interventions": [ { "name": "Conditioning Regimen", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 5, "start_date": "2003-06", "completion_date": "2009-07", "has_results": false, "last_update_posted_date": "2017-12-27", "last_synced_at": "2026-09-27T04:09:38.777Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00063817" }, { "nct_id": "NCT00192452", "title": "Study of MEDI-507 Administered by Intravenous Infusion to Adults With Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "MEDI-507", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "MedImmune LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 120, "start_date": "2001-03", "completion_date": "2001-12", "has_results": false, "last_update_posted_date": "2006-10-25", "last_synced_at": "2026-09-27T04:09:38.777Z", "location_count": 3, "location_summary": "Phoenix, Arizona • Winston-Salem, North Carolina • Tacoma, Washington", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Winston-Salem", "state": "North Carolina" }, { "city": "Tacoma", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00192452" }, { "nct_id": "NCT01445535", "title": "Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "T-Cell Peripheral Lymphoma", "Gamma Delta Hepatosplenic T-Cell Lymphoma", "Subcutaneous Panniculitis-Like T-Cell Lymphoma", "NK T-Cell Lymphoma" ], "interventions": [ { "name": "Rituximab", "type": "BIOLOGICAL" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Siplizumab", "type": "BIOLOGICAL" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Vincristine", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 15, "start_date": "2009-01-13", "completion_date": "2020-10-22", "has_results": true, "last_update_posted_date": "2021-11-03", "last_synced_at": "2026-09-27T04:09:38.777Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01445535" }, { "nct_id": "NCT04803006", "title": "A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PANORAMA)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Kidney Transplantation" ], "interventions": [ { "name": "TCD601", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "ITB-Med LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 4, "start_date": "2023-01-17", "completion_date": "2025-10-30", "has_results": false, "last_update_posted_date": "2026-02-06", "last_synced_at": "2026-09-27T04:09:38.777Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04803006" }, { "nct_id": "NCT00131066", "title": "Long-Term Follow-Up Study of Psoriasis Patients", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "Follow up from previous treatment with MEDI-507", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "MedImmune LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 200, "start_date": "2002-08", "completion_date": "2007-12", "has_results": false, "last_update_posted_date": "2008-09-22", "last_synced_at": "2026-09-27T04:09:38.777Z", "location_count": 7, "location_summary": "Little Rock, Arkansas • Denver, Colorado • Alpharetta, Georgia + 4 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Denver", "state": "Colorado" }, { "city": "Alpharetta", "state": "Georgia" }, { "city": "Springfield", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00131066" }, { "nct_id": "NCT05669001", "title": "A Study of TCD601 in de Novo Renal Transplant Recipients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Renal Transplantation" ], "interventions": [ { "name": "TCD601", "type": "BIOLOGICAL" }, { "name": "belatacept", "type": "BIOLOGICAL" }, { "name": "ATG", "type": "DRUG" }, { "name": "TAC", "type": "DRUG" }, { "name": "MPA", "type": "DRUG" }, { "name": "Corticosteroids", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "ITB-Med LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 76, "start_date": "2023-12-28", "completion_date": "2026-04-10", "has_results": false, "last_update_posted_date": "2026-05-05", "last_synced_at": "2026-09-27T04:09:38.777Z", "location_count": 18, "location_summary": "Sacramento, California • San Francisco, California • Tampa, Florida + 15 more", "locations": [ { "city": "Sacramento", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05669001" }, { "nct_id": "NCT07508787", "title": "A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Renal Transplant Failure and Rejection" ], "interventions": [ { "name": "Siplizumab", "type": "DRUG" }, { "name": "Rabbit anti-thymocyte globulin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nefro Avillion Clinical Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 120, "start_date": "2026-06-29", "completion_date": "2028-03-28", "has_results": false, "last_update_posted_date": "2026-09-02", "last_synced_at": "2026-09-27T04:09:38.777Z", "location_count": 7, "location_summary": "Sacramento, California • Tampa, Florida • Atlanta, Georgia + 4 more", "locations": [ { "city": "Sacramento", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Livingston", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT07508787" } ] }